Page last updated: 2024-09-05

lenalidomide and Diabetic Retinopathy

lenalidomide has been researched along with Diabetic Retinopathy in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dong, LF; Jiang, Q; Shan, K; Wang, XQ; Yan, B; Yang, H; Yao, J	1

Other Studies

1 other study(ies) available for lenalidomide and Diabetic Retinopathy

Article	Year
Lenalidomide, an anti-tumor drug, regulates retinal endothelial cell function: Implication for treating ocular neovascular disorder. Biochemical and biophysical research communications, 2015, Oct-02, Volume: 465, Issue:4 Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Line; Cell Movement; Cell Survival; Choroidal Neovascularization; Diabetic Retinopathy; Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation Mediators; Lenalidomide; Macaca mulatta; Mice; Retinal Neovascularization; Retinal Vessels; Thalidomide; Vascular Endothelial Growth Factor A	2015

Article

Year

Lenalidomide, an anti-tumor drug, regulates retinal endothelial cell function: Implication for treating ocular neovascular disorder.

Biochemical and biophysical research communications, 2015, Oct-02, Volume: 465, Issue:4

Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Cell Line; Cell Movement; Cell Survival; Choroidal Neovascularization; Diabetic Retinopathy; Endothelial Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Inflammation Mediators; Lenalidomide; Macaca mulatta; Mice; Retinal Neovascularization; Retinal Vessels; Thalidomide; Vascular Endothelial Growth Factor A

2015